Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation

References

• Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian cardiovascular society/Canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36(12):1847–1948. doi:10.1016/j.cjca.2020.09.001
   PubMed Web of Science ®Google Scholar
• Choi SE, Sagris D, Hill A, et al. Atrial fibrillation and stroke. Expert Rev Cardiovasc Ther. 2023;21(1):35–56. doi:10.1080/14779072.2023.2160319
   PubMed Web of Science ®Google Scholar
• Cesari M, Prince M, Thiyagarajan JA, et al. Frailty: an emerging public health priority. J Am Med Dir Assoc. 2016;17(3):188–192. doi:10.1016/j.jamda.2015.12.016
   PubMed Web of Science ®Google Scholar
• Kim D, Yang PS, Sung JH, et al. Effectiveness and safety of anticoagulation therapy in frail patients with atrial fibrillation. Stroke. 2022;53(6):1873–1882. doi:10.1161/STROKEAHA.121.036757
   PubMed Web of Science ®Google Scholar
• Proietti M, Romiti GF, Vitolo M, et al. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe. Age Ageing. 2022;51(8):afac192. doi:10.1093/ageing/afac192
   PubMed Web of Science ®Google Scholar
• Oldgren J, Åsberg S, Hijazi Z, et al. Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study. Circulation. 2022;146(14):1056–1066. doi:10.1161/CIRCULATIONAHA.122.060666
   PubMed Web of Science ®Google Scholar
• Beezer J, Al Hatrushi M, Husband A, et al. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev. 2022;27(2):465–492. doi:10.1007/s10741-021-10135-4
   PubMed Web of Science ®Google Scholar
• Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a Review. Eur J Intern Med. 2016;31:3–10. doi:10.1016/j.ejim.2016.03.007
   PubMed Web of Science ®Google Scholar
• Krempley T, Schmidt EK. Assessing activity of daily living task performance among autistic adults. Autism Adulthood. 2021;3(1):37–51. doi:10.1089/aut.2020.0042
   PubMedGoogle Scholar
• Carnero-Pardo C, Rego-García I, Barrios-López JM, et al. Assessment of the diagnostic accuracy and discriminative validity of the clock drawing and mini-cog tests in detecting cognitive impairment. Neurologia. 2022;37(1):13–20. doi:10.1016/j.nrleng.2018.12.022
   Web of Science ®Google Scholar
• Liu H, Jiao J, Zhu M, et al. Nutritional status according to the short-form mini nutritional assessment (MNA-SF) and clinical characteristics as predictors of length of stay, mortality, and readmissions among older inpatients in china: a national study. Front Nutr. 2022;9:815578. doi:10.3389/fnut.2022.815578
   PubMed Web of Science ®Google Scholar
• Kim YJ, Choi KO, Cho SH, et al. Validity of the morse fall scale and the Johns Hopkins fall risk assessment tool for fall risk assessment in an acute care setting. J Clin Nurs. 2022;31(23–24):3584–3594. doi:10.1111/jocn.16185
   PubMed Web of Science ®Google Scholar
• Di Donato V, O D, Giannini A, et al. Age-adjusted Charlson comorbidity index predicts survival in endometrial cancer patients. Gynecol Obstet Invest. 2022;87(3–4):191–199. doi:10.1159/000525405
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery. for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• Meeusen JW, Kasozi RN, Larson TS, et al. Clinical impact of the refit CKD-EPI 2021 creatinine-based eGFR. Equation Clin Chem. 2022;68(4):534–539. doi:10.1093/clinchem/hvab282
   PubMed Web of Science ®Google Scholar
• Calsolaro V, Okoye C, Antognoli R, et al. Long-term effectiveness and safety of anticoagulation therapy in oldest old, frail people with atrial fibrillation. Eur J Intern Med. 2021;86:91–97. doi:10.1016/j.ejim.2021.01.020
   PubMed Web of Science ®Google Scholar
• Proietti M, Romiti GF, Raparelli V, et al. Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients. Ageing Res Rev. 2022;79:101652. doi:10.1016/j.arr.2022.101652
   PubMed Web of Science ®Google Scholar
• Guo Q, Du X, Ma CS. Atrial fibrillation and frailty. J Geriatr Cardiol. 2020;17(2):105–109. doi:10.11909/j.issn.1671-5411.2020.02.007
   PubMedGoogle Scholar
• Bahri O, Roca F, Lechani T, et al. Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude. J. Am Geriatr Soc. 2015;63(1):71–76. doi:10.1111/jgs.13200
   PubMed Web of Science ®Google Scholar
• Wu VC, Huang YC, Chen SW, et al. Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage. Medicine. 2021;100(32):e26945. doi:10.1097/MD.0000000000026945
   PubMed Web of Science ®Google Scholar
• Raposeiras-Roubín S, Abu-Assi E, Paz RC, et al. Impact of malnutrition in the embolic-haemorrhagic trade-off of elderly patients with atrial fibrillation. Europace. 2020;22(6):878–887. doi:10.1093/europace/euaa017
   PubMed Web of Science ®Google Scholar
• Tsagkaris C, Papazoglou AS, Kartas A, et al. Polypharmacy and major adverse events in atrial fibrillation. J Cardiovasc Pharmacol. 2022;80(6):826–831. doi:10.1097/FJC.0000000000001339
   PubMedGoogle Scholar
• Patel P, Pandya J, Goldberg M. NOACs vs. Warfarin for stroke prevention in nonvalvular atrial fibrillation. Cureus. 2017;9(6):e1395. doi:10.7759/cureus.1395
   PubMed Web of Science ®Google Scholar
• Kido K, Shimizu M, Shiga T, et al. Meta-analysis comparing inappropriately low dose versus standard dose of direct oral anticoagulants in patients with atrial fibrillation. J Am Pharm Assoc. 2022;62(2):487–495. doi:10.1016/j.japh.2021.10.027
   Google Scholar
• Romiti GF, Proietti M, Vitolo M, et al. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURO observational research programme in AF general long-term registry. BMC Med. 2022;20(1):326. doi:10.1186/s12916-022-02526-7
   PubMed Web of Science ®Google Scholar
• Trinks-Roerdink EM, Geersing GJ, van den Dries CJ, et al. Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial. PLoS One. 2023;18(10):e0292586. doi:10.1371/journal.pone.0292586
   PubMed Web of Science ®Google Scholar